VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 637 filers reported holding VANECK VECTORS ETF TR in Q3 2022. The put-call ratio across all filers is 0.65 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $230,685 | +8.9% | 6,798 | -3.4% | 0.01% | -26.7% |
Q2 2023 | $211,826 | -95.1% | 7,035 | -94.7% | 0.02% | -95.5% |
Q1 2023 | $4,311,343 | +15.7% | 133,271 | +2.5% | 0.33% | +6.8% |
Q4 2022 | $3,727,054 | +34.0% | 130,043 | +12.7% | 0.31% | +6.1% |
Q3 2022 | $2,782,000 | +48.6% | 115,348 | +68.7% | 0.29% | +72.4% |
Q2 2022 | $1,872,000 | -34.6% | 68,362 | -8.5% | 0.17% | -27.0% |
Q1 2022 | $2,864,000 | +34.4% | 74,681 | +12.2% | 0.23% | +52.3% |
Q4 2021 | $2,131,000 | -0.5% | 66,531 | -8.4% | 0.15% | -16.4% |
Q3 2021 | $2,141,000 | +14.1% | 72,655 | +31.6% | 0.18% | +10.2% |
Q2 2021 | $1,876,000 | +108.2% | 55,197 | +99.0% | 0.17% | +72.9% |
Q1 2021 | $901,000 | +6.5% | 27,735 | +18.0% | 0.10% | -17.9% |
Q4 2020 | $846,000 | -1.3% | 23,496 | +7.4% | 0.12% | -44.0% |
Q3 2020 | $857,000 | +68.7% | 21,881 | +57.9% | 0.21% | +34.0% |
Q2 2020 | $508,000 | -77.6% | 13,854 | -83.6% | 0.16% | -82.0% |
Q3 2019 | $2,263,000 | – | 84,719 | – | 0.87% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |